Strategic Overview of Global Preventable Vaccine Market

1
(No Transcript)
2
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Report Details

• Publish date 12th Apr, 2013
• Number of slides 111
• Geographic coverage Global
• Available format PDF, CD, Hardcopy
• Price for Single User License USD 3,000
• Price for Three User License USD 3,200
• Price for Five User License USD 3,300
• Price for Global Site License USD 4,000
• Delivery Time Within 1 business day
• Payment Modes Credit/Debit Card, RTGS/Wire
  Transfer, Google Wallet, PayPal

3
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Report Insights

• The strategic overview of global preventable
  vaccine market is projected to grow at a CAGR of
  8.99 over 2012 to 2016
• One of the key factors contributing to this
  market growth is the increase in demand for
  vaccination
• The market has also been witnessing an increase
  in market consolidation
• However, the emergence of regional players could
  pose a challenge to the growth of this market

4
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Report Coverage

• Size of the strategic overview of global
  preventable vaccine market in 2016 and its growth
  rate
• Key market trends and factors driving the growth
  of this market
• Challenges to market growth
• Key vendors in this market space
• Market opportunities and threats faced by key
  vendors
• Strengths and weaknesses of each of these key
  vendors

5
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Key Vendors

• GlaxoSmithKline plc
• Sanofi Pasteur SA
• Merck Co. Inc.
• Novartis AG
• Pfizer Inc.
• Emergent BioSolutions Inc.

6
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Table of Contents

• Executive Summary
• List of Abbreviations
• Introduction
• Market Research Methodology
• Scope of the Report
• Vaccine
• Global Preventable Vaccines Market
• Competitive Landscape of Global Preventable
  Vaccine Market
• Geographical Analysis of Global Preventable
  Vaccines Market
• Global Pediatric Preventable Vaccines Market

7
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Table of Contents (Continued)

• Pipeline Assessment of Pediatric Preventable
  Vaccine Market
• Competitive Landscape of Global Pediatric
  Preventable Vaccine Market
• Geographical Segmentation of Pediatric
  Preventable Vaccine Market
• Global Pediatric Preventable Vaccines Market by
  Regions
• Global Adult Preventable Vaccines Market
• Pipeline Assessment of Adult Preventable Vaccine
  Market
• Competitive Landscape of Global Adult Preventable
  Vaccine Market
• Geographical Segmentation of Adult Preventable
  Vaccine Market
• Global Adult Preventable Vaccines Market by
  Regions

8
Report Strategic Overview of Global Preventable
Vaccine Market 2012-2016
Table of Contents (Continued)

• Buying Criteria
• Market Growth Drivers
• Drivers and their Impact
• Market Challenges
• Impact of Drivers and Challenges
• Market Trends
• Key Vendor Analysis
• Other Reports in this Series

9
Interested in this report?
To view more details regarding this premium
market research report, Please click here
For further information, get in touch with us
E-mail support_at_researchonglobalmarkets.com Call
US 1 866 325 7446 UK 44 203 514 2363 Others
91 22 4098 7600
About Us Research on Global Markets is a leading
source for market research on various sectors
globally offering premium research content from
worldwide publishers of market research reports
Industry Segments Industry Segments Industry Segments
Automotive Transport Consumer goods Agriculture
Food and Beverage Energy and Utilities Public Sector
Manufacturing Construction Healthcare Media Entertainment
IT, Telecom Electronics Services Others